Anthony Sferruzza
Impact in
- Gastroenterology top 1%
- Celiac Disease Research and Management
-
- Microscopic Colitis
- Liver Disease Diagnosis and Treatment
Papers in
- Oncology 9
- CAR-T cell therapy research 3
-
- Platelet Disorders and Treatments 3
- Co-authors
- Craig Sturgeon (1 shared paper)Bushra Bhatti (1 shared paper)Daniel Gelfond (1 shared paper)Debby Kryszak (1 shared paper)Alessio Fasano (1 shared paper)Kathy J. Helzlsouer (1 shared paper)Carlo Catassi (1 shared paper)Elaine Leonard Puppa (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (3 papers)Anti-Cancer Drugs (2 papers)Clinical Chemistry (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Anthony Sferruzza
21 papers receiving 651 citations
Peers
Comparison fields: 5 of 56
- Gastroenterology 282
- Epidemiology 203
- Oncology 160
- Hepatology 44
- Immunology 115
Countries citing papers authored by Anthony Sferruzza
This map shows the geographic impact of Anthony Sferruzza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Sferruzza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Sferruzza more than expected).
Fields of papers citing papers by Anthony Sferruzza
This network shows the impact of papers produced by Anthony Sferruzza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Sferruzza. The network helps show where Anthony Sferruzza may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Sferruzza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 302 | |
| 2 | 1991 | 92 | |
| 3 | 2009 | 61 | |
| 4 | 2007 | 53 | |
| 5 | 2013 | 47 | |
| 6 | 1989 | 31 | |
| 7 | 2002 | 24 | |
| 8 | 2011 | 17 | |
| 9 | 1982 | 15 | |
| 10 | Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial. | 1991 | 15 |
| 11 | 2009 | 12 | |
| 12 | 2006 | 11 | |
| 13 | 2009 | 3 | |
| 14 | 2007 | 3 | |
| 15 | 2003 | 2 | |
| 16 | 2007 | 2 | |
| 17 | 2009 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2006 | 1 |
About Anthony Sferruzza
Anthony Sferruzza is a scholar working on Oncology, Hematology, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 21 papers that have together received 695 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (3 papers), CAR-T cell therapy research (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Cancer, Lipids, and Metabolism (2 papers), Computational Drug Discovery Methods (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Immunotherapy and Immune Responses (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Gastroenterology (282 citations), Epidemiology (203 citations), Oncology (160 citations), Hepatology (44 citations) and Immunology (115 citations). Anthony Sferruzza has collaborated with scholars based in United States and Italy. Frequent co-authors include Craig Sturgeon, Bushra Bhatti, Daniel Gelfond, Debby Kryszak, Alessio Fasano, Kathy J. Helzlsouer, Carlo Catassi, Elaine Leonard Puppa, Sandra Clipp and Richard A. Bender. Their work appears in journals such as Journal of Clinical Oncology, Blood, Anti-Cancer Drugs, Clinical Chemistry and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.